Company intelligence / Profile preview

ELIQUENT Life Sciences

Washington DC, District of Columbia, United Stateseliquent.com ↗

Ownership: Private
Development stage: Other

Overview

ELIQUENT Life Sciences is a leading global regulatory and quality compliance consulting group serving pharmaceutical, biotechnology, medical device, and combination product companies. It was formed by uniting five major consultancies—Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, and IDEC—into one brand in 2024. The firm delivers strategic guidance across regulatory affairs, pharmacovigilance/safety surveillance (PV), quality/compliance remediation solutions worldwide. Its team includes former FDA/EMA leaders and industry experts with deep experience supporting market authorization globally.

Modalities: Monoclonal antibodyEnzyme replacement therapyBiosimilarTissue-based therapyVaccine
Industry: Consulting

Beyond the preview

Go deeper on ELIQUENT Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELIQUENT Life Sciences.

Explore the full profile